Top Page
Fortis Healthcare Ltd.
(FORTIS)
Fortis Healthcare Ltd. (FORTIS) vs. iShares MSCI India ETF (INDA)
Fortis Healthcare Ltd. Business Overview & Revenue Model
Fortis Healthcare Ltd. Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 80.91B | 77.86B | 68.97B | 62.98B | 57.18B | 40.30B |
| Gross Profit | 32.14B | 45.86B | 39.73B | 23.08B | 32.25B | 20.72B |
| EBITDA | 16.45B | 15.00B | 11.87B | 10.37B | 9.96B | 3.47B |
| Net Income | 8.69B | 7.74B | 5.99B | 5.89B | 5.55B | -1.10B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 136.92B | 132.89B | 124.34B | 118.85B | 111.55B |
| Cash, Cash Equivalents and Short-Term Investments | 5.06B | 5.08B | 6.00B | 3.66B | 4.13B | 4.16B |
| Total Debt | 0.00 | 24.75B | 11.55B | 9.26B | 12.55B | 15.31B |
| Total Liabilities | -91.69B | 45.22B | 47.33B | 43.33B | 48.76B | 44.37B |
| Stockholders Equity | 91.69B | 89.17B | 76.63B | 72.42B | 61.78B | 61.20B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.77B | 1.58B | 3.75B | 6.50B | 2.67B |
| Operating Cash Flow | 0.00 | 14.24B | 11.00B | 8.22B | 8.65B | 4.85B |
| Investing Cash Flow | 0.00 | -7.79B | -8.86B | -3.74B | -5.14B | -1.35B |
| Financing Cash Flow | 0.00 | -7.14B | -864.58M | -4.71B | -5.17B | -1.43B |
Fortis Healthcare Ltd. Technical Analysis
Fortis Healthcare Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ₹387.61B | 45.64 | ― | 0.24% | 14.72% | 8.37% | |
66 Neutral | ₹1.04T | 62.43 | ― | 0.27% | 13.66% | 41.32% | |
66 Neutral | ₹237.42B | 44.23 | ― | 0.89% | 10.80% | 32.79% | |
61 Neutral | ₹681.12B | 67.17 | ― | 0.11% | 15.33% | 54.62% | |
61 Neutral | ₹99.74B | 62.88 | ― | 0.21% | 15.41% | 5.93% | |
59 Neutral | ₹908.07B | 51.56 | ― | 0.04% | 23.22% | -19.19% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
Fortis Healthcare Ltd. Corporate Events
Fortis Healthcare has announced a series of in-person investor and analyst meetings in the United States in January 2026, including a non-deal roadshow in New York and Boston organized by J.P. Morgan and participation in the J.P. Morgan 2026 Healthcare Conference in San Francisco. The sessions, which will feature one-on-one and group meetings focused on general business and industry updates, underscore the company’s efforts to deepen engagement with global investors, enhance transparency, and potentially strengthen its visibility and positioning within the international healthcare investment community, while confirming that no unpublished price-sensitive information will be shared and related presentations will be publicly disclosed in advance.
Fortis Healthcare has announced a series of upcoming investor and analyst interactions, including an in-person non-deal roadshow organized by J.P. Morgan in New York and Boston on January 12–13, 2026, and participation in the J.P. Morgan 2026 Healthcare Conference in San Francisco on January 15, 2026. These one-on-one and group meetings, aimed at providing a general business and industry update without sharing unpublished price-sensitive information, underscore the company’s efforts to deepen engagement with global investors and analysts, potentially enhancing its visibility and positioning in international capital markets.
Fortis Healthcare Limited has announced a schedule of upcoming investor and analyst interactions in the United States, including a non-deal roadshow organized by J.P. Morgan in New York and Boston on January 12–13, 2026, and participation in the J.P. Morgan 2026 Healthcare Conference in San Francisco on January 15, 2026. The meetings, to be held in person through one-on-one and group formats, are intended to provide a general business and industry update, with the company emphasizing that no unpublished price-sensitive information will be shared and that the related investor presentation will be disclosed to stock exchanges in advance, underscoring its focus on regulatory compliance and transparent engagement with global investors.
Fortis Healthcare’s wholly owned subsidiary, International Hospital Limited, has signed definitive agreements to acquire TMI Healthcare Private Limited, which primarily comprises hospital operations, along with the underlying hospital land, building and an adjacent land parcel in Bengaluru. The deal, which centers on the People Tree Hospital in Yeshwanthpur (with related facilities to be carved out before closing), aligns with Fortis’s cluster-focused growth strategy and is intended to further consolidate its network and competitive position in the Bengaluru healthcare market, though completion remains subject to customary conditions precedent and closing conditions.
Fortis Healthcare has signed definitive agreements to acquire the 125-bed People Tree Hospital in Yeshwanthpur, Bengaluru, through its wholly owned subsidiary International Hospital Limited by purchasing 100% of TMI Healthcare Private Limited and related real estate assets for a cumulative transaction value of INR 430 crore, including debt. The deal, which is expected to close by the end of January 2026, includes the acquisition of an adjacent 0.8-acre land parcel that will allow Fortis to expand the facility to more than 300 beds, supported by an additional planned investment of about INR 410 crore over the next three years in infrastructure, medical equipment and clinical programs such as radiation oncology; this move strengthens Fortis’s cluster-based expansion strategy in Bengaluru, enhancing its presence from the current 900 beds toward a potential 1,500-plus beds across seven facilities and positioning the company to grow revenues and profitability from the hospital’s existing business base.
Fortis Healthcare Limited announced the publication of newspaper advertisements regarding the completion of electronic transmission of a Postal Ballot Notice to its members. This announcement is part of the company’s compliance with SEBI regulations, ensuring transparency and communication with its stakeholders.
Fortis Healthcare Limited has reported details of its debt securities issued through private placement as per the SEBI Master Circular. The company has listed debt securities with an issuance date of December 19, 2024, and a maturity date of December 19, 2029, with an initial coupon rate of 8.486% per annum. This announcement is part of their compliance with regulatory requirements and reflects the company’s ongoing financial management strategy.